Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fenaux

Showing results (201-210 of 320) with videos related to

Pageof 32
Sort By:
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[(9;11) (p21;q23) translocation: apropos of 2 new cases seen in acute undifferentiated monoblastic AML5a leukemia]J L Laï, J P Jouet, M Zandecki, et al.
Leukemia|March 1, 1993
Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemiaE Archimbaud, P Fenaux, J Reiffers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemiaP Fenaux, G Tertian, S Castaigne, et al.
Acta Haematologica|January 1, 1987
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literatureC Chomienne, Y Najean, L Degos, et al.
Leukemia|November 1, 1995
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)T de Witte, S Suciu, M Peetermans, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignanciesA Ulusakarya, E Chachaty, J M Vantelon, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases]M Zandecki, B Dupriez, J L Laï, et al.
Leukemia|February 20, 2003
Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blastsV Ribrag, F Suzan, C Ravoet, et al.
Bone Marrow Transplantation|April 21, 2001
Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapyJ M Vantelon, J N Munck, J H Bourhis, et al.
British Journal of Haematology|July 1, 1992
Rare occurrence of P53 gene mutations in multiple myelomaC Preudhomme, T Facon, M Zandecki, et al.
Pageof 32

Showing results (201-210 of 320) with videos related to

Sort By:
Pageof 32
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[(9;11) (p21;q23) translocation: apropos of 2 new cases seen in acute undifferentiated monoblastic AML5a leukemia]J L Laï, J P Jouet, M Zandecki, et al.
Leukemia|March 1, 1993
Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemiaE Archimbaud, P Fenaux, J Reiffers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemiaP Fenaux, G Tertian, S Castaigne, et al.
Acta Haematologica|January 1, 1987
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literatureC Chomienne, Y Najean, L Degos, et al.
Leukemia|November 1, 1995
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)T de Witte, S Suciu, M Peetermans, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignanciesA Ulusakarya, E Chachaty, J M Vantelon, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases]M Zandecki, B Dupriez, J L Laï, et al.
Leukemia|February 20, 2003
Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blastsV Ribrag, F Suzan, C Ravoet, et al.
Bone Marrow Transplantation|April 21, 2001
Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapyJ M Vantelon, J N Munck, J H Bourhis, et al.
British Journal of Haematology|July 1, 1992
Rare occurrence of P53 gene mutations in multiple myelomaC Preudhomme, T Facon, M Zandecki, et al.
Pageof 32